STRM.BIO
STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient, safe, and practical manner. STRM.BIO aims to fulfill the promise of gene therapy by using extracellular vesicles to deliver treatment directly to the patient. The natural carriers of nucleic acids and proteins with innate targeting capabilities, the ability to be mass-produced on a large scale commercially, and low immunogenicity.
STRM.BIO
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.strm.bio
Total Employee:
1+
Status:
Active
Total Funding:
2.1 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Google Maps LetsEncrypt SSL By Default
Similar Organizations
Bolt Threads
Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - STRM.BIO
NYBC Ventures
NYBC Ventures investment in Seed Round - STRM.BIO
NCATS
NCATS investment in Grant - STRM.BIO
Official Site Inspections
http://www.strm.bio Semrush global rank: 4.74 M Semrush visits lastest month: 1.94 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "STRM.BIO"
Leadership - STRM.BIO
STRM.BIO - Crunchbase Company Profile & Funding
STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient, safe, and practical manner. STRM.BIO aims to fulfill the promise of gene therapy by using extracellular vesicles to deliver …See details»
STRM.BIO Company Profile 2024: Valuation, Funding
STRM.BIO General Information Description. Operator of a biotechnology company intended to deliver gene therapy treatment directly to the patient. The company is leveraging extracellular vesicles (EVs) to establish a whole new …See details»
STRM.BIO - Org Chart, Teams, Culture & Jobs - The Org
Strm.bio 0 followers Based in Boston, MA, STRM.BIO (“storm bio”) is a pre-clinical, VC-backed biotechnology company that aims to fulfill the promise of gene therapy by leveraging …See details»
RePORT 〉 RePORTER
STRM.BIO is developing a scalable, extracellular vesicle (EV)-based gene therapy platform for in vivo delivery that naturally homes to bone marrow stem cells and is amenable to repeat …See details»
STRM.BIO | Our Companies - Ascension Ventures
Based in Boston, MA, STRM.BIO is a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to deliver gene therapy in a better way: simpler, safer, …See details»
STRM.BIO: Contact Details and Business Profile - RocketReach
Based in Boston, MA, STRM.BIO (“storm bio”) is a pre-clinical, VC-backed biotechnology company that aims to fulfill the promise of gene therapy by leveraging extracellular vesicles …See details»
STRM.Bio Incorporated | VentureRadar
Based in Cambridge MA, STRM.BIO is a pre-clinical, VC-backed biotechnology company leveraging extracellular vesicles as a platform to develop and deliver targeted gene therapies …See details»
STRM.BIO - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 3, 2023: Grant - …See details»
Transforming Gene Therapy: Venture Profile - STRM.blog
Aug 19, 2022 Like many other companies, STRM.BIO is addressing the challenges of a hybrid model. “There are instances when we benefit from bringing people together,” Thon said. Thon and the rest of the STRM.BIO team are …See details»
Asked and Answered: Jonathan Thon Talks about Bringing Gene …
Aug 16, 2022 Doherty: Which applications of gene therapy is STRM.BIO focused on? Thon: STRM.BIO is initially focused on the major unmet need which resides at the intersection of …See details»
STRM.BIO - Products, Competitors, Financials, Employees, …
STRM.BIO is a pre-clinical biotechnology company focused on leveraging extracellular vesicles for gene therapy delivery in the biotechnology sector. The company's main offerings include …See details»
STRM.BIO - Overview, News & Similar companies | ZoomInfo.com
Oct 19, 2023 Who is STRM.BIO. About STRM.BIO Based in Boston, MA, STRM.BIO is a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to …See details»
Careers - STRM.BIO
STRM.BIO is growing. if you share our values and believe in the promise of EVs, we want to hear from you. ... We’re creating a culture where people come first, and where personal …See details»
STRM.Bio Incorporated - CAGE.report
Mar 12, 2020 STRM.Bio Incorporated Trade Name ("Doing Business As ..."): DUNS Number: 117447598 Parent DUNS Number: Address, line 1: 251 River St Address, line 2: City: ...See details»
Founder Spotlight #20: Jonathan Thon @ STRM.BIO - Medium
May 13, 2021 STRM.BIO is still quite young but we have already been very successful in recruiting an exceptional team, created strong academic and industry partnerships, united an …See details»
STRM.BIO - Contacts, Employees, Board Members, Advisors
STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.See details»
Bringing Gene Therapy to Life - STRM.blog
Jan 26, 2024 At STRM.BIO, we’re applying a non-viral platform using microvesicles derived from megakaryocytes to deliver gene therapies in vivo. STRM.BIO, Bringing Gene Therapy to Life . …See details»